Clinical research faces its greatest hurdle when experimental treatments fail to meet safety or efficacy endpoints. This process, known as drug trial failure, occurs during phased testing, halting development to protect patients. While costly for sponsors, the data gleaned prevents harmful market releases. Ultimately, future patients, researchers, and regulatory bodies benefit from refined protocols and redirected scientific investment.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends